Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells

Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention

(2015) Manabu Ogita et al.   AMERICAN JOURNAL OF CARDIOLOGY

On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects

(2015) Hagai Tavori et al.   ATHEROSCLEROSIS

Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)

(2015) Rainer Schulz et al.   BASIC RESEARCH IN CARDIOLOGY

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition

(2015) Nathalie Bergeron et al.   CIRCULATION

PCSK9: A key factor modulating atherosclerosis

(2015) Sha Li et al.   Journal of Atherosclerosis and Thrombosis

Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line

(2015) Massimiliano Ruscica et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice

(2015) Vikram Ravindra Shende et al.   JOURNAL OF LIPID RESEARCH

Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease

(2014) Sha Li et al.   ATHEROSCLEROSIS

PCSK9

(2014) Nabil G. Seidah et al.   CIRCULATION RESEARCH

Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease

(2014) Yan Zhang et al.   Journal of Clinical Lipidology

Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells

(2014) Mi-Hsueh Tai et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis

(2013) Janna A. van Diepen et al.   ATHEROSCLEROSIS

High-Sensitivity C-Reactive Protein and Cardiovascular Disease

(2013) Omair Yousuf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inflammation in Atherosclerosis

(2012) Peter Libby   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle interventions

(2012) D. Young et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

CRP promotes MMP-10 expression via c-Raf/MEK/ERK and JAK1/ERK pathways in cardiomyocytes

(2011) Chuanjue Cui et al.   CELLULAR SIGNALLING

Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters

(2010) Bin Dong et al.   JOURNAL OF LIPID RESEARCH

CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-κB and ERK 1/2 MAPK pathway

(2009) YangXin Chen et al.   FEBS LETTERS

The connection between C‐reactive protein and atherosclerosis

(2008) Sanjay K. Singh et al.   ANNALS OF MEDICINE

Inflammation stimulates the expression of PCSK9

(2008) Kenneth R. Feingold et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS